drugset / Trial / NCT00784394

Diindolylmethane in Preventing Cancer in Healthy Volunteers

NCT00784394 ↗

Phase 1 Completed 20 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupDouble-blindPrevention

Summary

This phase I clinical trial studies the side effects and best dose of diindolylmethane in preventing cancer in healthy volunteers. Diindolylmethane is formed in the stomachs of people who eat a chemical that is normally found in vegetables, including cabbage, broccoli, Brussels sprouts, cauliflower, and watercress. Diindolylmethane may prevent the development of cancer.

Timeline

Start
2004-04
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject ARUNDINE Small molecule — Oral

Indications

No indication recorded.